Publications


The role of striatal glutamate receptors in models of Parkinson's disease. K Ossowska, E Lorenc-Koci, J Konieczny, S Wolfarth
Amino acids,
PMID:9871435

Wednesday, 13 January 1999
Pharmacological profile of venlafaxine, a new antidepressant, given acutely. Z Rogóz, M Dziedzicka-Wasylewska, J Maj
Polish journal of pharmacology,
PMID:9798262

Friday, 8 January 1999
Changes in dopamine receptor mRNA expression following chronic mild stress and chronic antidepressant treatment. M Dziedzicka-Wasylewska, P Willner, M Papp
Behavioural pharmacology,
PMID:9832973

Tuesday, 29 December 1998
Effect of desipramine on immunological parameters in mice, and their reversal by stress. M Kubera, V Holan, A Basta-Kaim, A Roman, J Borycz, J Shani
International journal of immunopharmacology,
PMID:9778103

Friday, 11 December 1998
Agonists of A1 and A2A adenosine receptors attenuate methamphetamine-induced overflow of dopamine in rat striatum. K Golembiowska, A Zylewska
Brain research,
PMID:9739141

Friday, 20 November 1998
Effect of antidepressant drugs administered repeatedly on the dopamine D3 receptors in the rat brain. J Maj, M Dziedzicka-Wasylewska, R Rogoz, Z Rogóz
European journal of pharmacology,
PMID:9698202

Thursday, 12 November 1998
Effect of EMD 57445, the selective sigma receptor ligand, on the turnover and release of dopamine. G Skuza, K Gołembiowska, K Wedzony
Polish journal of pharmacology,
PMID:9662740

Thursday, 1 October 1998
Muscle rigidity induced by fluphenazine in rats is antagonized by L-DOPA, an antiparkinsonian drug. K Ossowska, J Konieczny, E Lorenc-Koci, G Schulze, H Coper, S Wolfarth
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society,
PMID:9670114

Thursday, 1 October 1998
Repeated trimipramine induces dopamine D2/D3 and alpha1-adrenergic up-regulation. J Maj, Z Rogóz, G Skuza, W Margas
Journal of neural transmission (Vienna, Austria : 1996),
PMID:9660111

Wednesday, 16 September 1998